MACRA, MIPS & APMs Oh My!
MACRA represents a transformative shift in the direction of physician payment, and will impact strategy across the provider community. CMS contends that parts of MACRA are working and parts need a redo. Do Mindy and Ryan agree? Is MACRA achieving its intended goals of improving quality and lowering costs? They will discuss the recently concluded “transition” year and what to expect in 2018.
Next Podcast
20 April 2018
Let’s Make a Deal
Previous Podcast
15 February 2018
It’s Launch Time
Listen now
Direct by Design: How Pharma can Lead the Future of Patient Experience and Interoperability
Discover how pharmaceutical companies can enhance patient experience and interoperability through direct-to-patient (DTP) models.
Read moreAI-Powered Decision Making to Simplify Your Launch Journey: Vynamic Experts on LaunchNav
LaunchNav by Inizio simplifies pharma launches with AI-driven insights, real-time benchmarks, and 800+ launch learnings.
Read moreThe One Big Beautiful Bill Act: Implications for the U.S. Health Industry
OBBBA reshapes U.S. healthcare with $1.2T cuts, shifting risk to providers, payers, and pharma. Explore impacts and strategies.
Read more